OMX Nordic 40
2.523,26
PKT
-13,16
PKT
-0,52
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.08.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 16.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 16.08.19 | AstraZeneca overweight | Barclays Capital | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.08.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.08.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 12.08.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 12.08.19 | Novo Nordisk Reduce | HSBC | |
| 12.08.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 09.08.19 | AstraZeneca overweight | Barclays Capital | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.19 | A.P. Moeller - Maersk A-S (B) neutral | Morgan Stanley | |
| 07.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.08.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 05.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.07.19 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.07.19 | Nokia Outperform | Credit Suisse Group | |
| 26.07.19 | Nokia buy | Deutsche Bank AG | |
| 26.07.19 | ABB (Asea Brown Boveri) neutral | Morgan Stanley | |
| 26.07.19 | AstraZeneca overweight | Barclays Capital | |
| 26.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG |